Close
4

Bora CDMO Bora CDMO

X

CAS 13529-31-2 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 13529-31-2
Also known as: 13529-31-2, (2b,3a,16b,17b)-2,16-bispiperidino-3,17-diacetoxy-5-androstane, N738ko204j, Vecuronium bromide related compound a, [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-17-acetyloxy-10,13-dimethyl-2,16-di(piperidin-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate, Androstane-3,17-diol, 2,16-di-1-piperidinyl-, 3,17-diacetate, (2beta,3alpha,5alpha,16beta,17beta)-
Molecular Formula
C33H54N2O4
Molecular Weight
542.8  g/mol
InChI Key
CSXHRHGXNQSNQW-ZZZJANDJSA-N
FDA UNII
N738KO204J

1 2D Structure

CAS 13529-31-2

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-di(piperidin-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
2.1.2 InChI
InChI=1S/C33H54N2O4/c1-22(36)38-30-19-24-11-12-25-26(33(24,4)21-29(30)35-17-9-6-10-18-35)13-14-32(3)27(25)20-28(31(32)39-23(2)37)34-15-7-5-8-16-34/h24-31H,5-21H2,1-4H3/t24-,25+,26-,27-,28-,29-,30-,31-,32-,33-/m0/s1
2.1.3 InChI Key
CSXHRHGXNQSNQW-ZZZJANDJSA-N
2.1.4 Canonical SMILES
CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)N6CCCCC6)C
2.1.5 Isomeric SMILES
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)N6CCCCC6)C
2.2 Other Identifiers
2.2.1 UNII
N738KO204J
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 13529-31-2

2. (2b,3a,16b,17b)-2,16-bispiperidino-3,17-diacetoxy-5-androstane

3. N738ko204j

4. Vecuronium Bromide Related Compound A

5. [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-17-acetyloxy-10,13-dimethyl-2,16-di(piperidin-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] Acetate

6. Androstane-3,17-diol, 2,16-di-1-piperidinyl-, 3,17-diacetate, (2beta,3alpha,5alpha,16beta,17beta)-

7. Androstane-3,17-diol,2,16-di-1-piperidinyl-, 3,17-diacetate, (2b,3a,5a,16b,17b)-

8. Unii-n738ko204j

9. Pancuronium Bromide Specified Impurity E [ep]

10. Schembl5795960

11. Dtxsid201133509

12. 2beta,16beta-dipiperidino-5alpha-androstane-3alpha,17beta-diol Diacetate

13. Zinc118912865

14. (2beta,3alpha,5alpha,16beta,17beta)-2,16-bispiperidino-3,17-diacetoxy-5-androstane

15. D88040

16. 529d312

17. Pancuronium Bromide Impurity E [ep Impurity]

18. Vecuronium Bromide Impurity A [ep Impurity]

19. Q27284650

20. Vecuronium Bromide Related Compound A [usp-rs]

21. Vecuronium Bromide Related Compound A [usp Impurity]

22. 2b,3a,16b,17b)-2,16-bispiperidino-3,17-diacetoxy-5-androstane

23. (2?,3a,5a,16?,17?)-androstane-3,17-diol-2,16-di-1-piperidinyldiacetic Acid Ester

24. (2beta, 3alpha, 16beta, 17beta)-3,17-diacetoxy-2,16-dipiperidino-5alpha-androstane

25. 2.beta.,16.beta.-dipiperidino-5.alpha.-androstane-3.alpha.,17.beta.-diol Diacetate

26. (2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-2,16-bispiperidino-3,17-diacetoxy-5-androstane

27. 2.beta.,16.beta.-bis(piperidin-1-yl)-5.alpha.-androstane-3.alpha.,17.beta.-diyl Diacetate

28. Androstane-3,17-diol, 2,16-di-1-piperidinyl-, 3,17-diacetate, (2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-

2.4 Create Date
2007-02-09
3 Chemical and Physical Properties
Molecular Weight 542.8 g/mol
Molecular Formula C33H54N2O4
XLogP36.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass542.40835821 g/mol
Monoisotopic Mass542.40835821 g/mol
Topological Polar Surface Area59.1 Ų
Heavy Atom Count39
Formal Charge0
Complexity913
Isotope Atom Count0
Defined Atom Stereocenter Count10
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY